Figure 4D and Table 2 illustrate a decreasing trend in CBC severity within the PBM group (Before: 64.6 ± 25.7; 1 week: 63.9 ± 26.3; 2 weeks: 59.8 ± 25.1; 4 weeks: 56.1 ± 26.0), while the control group exhibited no change (Before: 57.0 ± 32.0; 1 week: 60.1 ± 31.7; 2 weeks: 58.2 ± 32.7; 4 weeks: 57.6 ± 32.5).
← all excerpts
Photobiomodulation therapy for congenital color vision deficiency: results of a preliminary randomized clinical trial.
1
—
—